These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20625403)

  • 21. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
    Savitt AG; Mena-Taboada P; Monsalve G; Benach JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):414-22. PubMed ID: 19176692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide.
    Roche MI; Lu Z; Hui JH; Sharon J
    Hybridoma (Larchmt); 2011 Feb; 30(1):19-28. PubMed ID: 21466282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Francisella tularensis Polysaccharides: What Is the Real Capsule?
    Freudenberger Catanzaro KC; Inzana TJ
    Microbiol Mol Biol Rev; 2020 May; 84(1):. PubMed ID: 32051235
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibodies to both terminal and internal B-cell epitopes of Francisella tularensis O-polysaccharide produced by patients with tularemia.
    Lu Z; Perkins HM; Sharon J
    Clin Vaccine Immunol; 2014 Feb; 21(2):227-33. PubMed ID: 24351753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a zwitterionic detergent for the restoration of the antibody binding capacity of immunoblotted Francisella tularensis lipopolysaccharide.
    Fulop MJ; Webber T; Manchee RJ
    Anal Biochem; 1992 May; 203(1):141-5. PubMed ID: 1524210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.
    Lindemann SR; Peng K; Long ME; Hunt JR; Apicella MA; Monack DM; Allen LA; Jones BD
    Infect Immun; 2011 Feb; 79(2):581-94. PubMed ID: 21078861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the O-antigen of Francisella tularensis strain 15.
    Vinogradov EV; Shashkov AS; Knirel YA; Kochetkov NK; Tochtamysheva NV; Averin SF; Goncharova OV; Khlebnikov VS
    Carbohydr Res; 1991 Jul; 214(2):289-97. PubMed ID: 1769021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance.
    Case ED; Chong A; Wehrly TD; Hansen B; Child R; Hwang S; Virgin HW; Celli J
    Cell Microbiol; 2014 Jun; 16(6):862-77. PubMed ID: 24286610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.
    Faron M; Fletcher JR; Rasmussen JA; Apicella MA; Jones BD
    PLoS One; 2015; 10(5):e0127458. PubMed ID: 26010977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of the Francisella tularensis Biofilm is Affected by Cell Surface Glycosylation, Growth Medium, and a Glucan Exopolysaccharide.
    Champion AE; Catanzaro KCF; Bandara AB; Inzana TJ
    Sci Rep; 2019 Aug; 9(1):12252. PubMed ID: 31439876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of the core part of the lipopolysaccharide O-antigen of Francisella novicida (U112).
    Vinogradov E; Perry MB
    Carbohydr Res; 2004 Jun; 339(9):1643-8. PubMed ID: 15183739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
    Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
    J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural analysis of a protective epitope of the Francisella tularensis O-polysaccharide.
    Rynkiewicz MJ; Lu Z; Hui JH; Sharon J; Seaton BA
    Biochemistry; 2012 Jul; 51(28):5684-94. PubMed ID: 22747335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
    Russo TA; Beanan JM; Olson R; MacDonald U; Cope JJ
    Vaccine; 2009 Jan; 27(3):388-95. PubMed ID: 19014988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
    Cherwonogrodzky JW; Knodel MH; Spence MR
    Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis.
    Kim TH; Sebastian S; Pinkham JT; Ross RA; Blalock LT; Kasper DL
    J Biol Chem; 2010 Sep; 285(36):27839-49. PubMed ID: 20605777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.